mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.5 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.5 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.5 |
mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.5 |
mRNA |
CMK |
GDSC1000 |
pan-cancer |
AAC |
-0.032 |
0.5 |
mRNA |
KIN001-244 |
GDSC1000 |
pan-cancer |
AAC |
0.018 |
0.5 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |